T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC

NCT00609219 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

BIOLOGICAL: autologous EBV specific CTLs

Sponsor

Baylor College of Medicine

Collaborators

[object Object]
[object Object]